QLYS just printed its biggest weekly move in months — up 19% to $161.06 — driven by an earnings beat that triggered a wave of analyst target increases. The tension worth watching is that a high short position at 10.6% of free float has barely budged, even as the stock surged.
The post-earnings analyst reaction was immediate and broad. Morgan Stanley's Hamza Fodderwala lifted his target from $115 to $130 on August 5, but held his Underweight rating — a notable signal that even after the rally, the most bearish bellwether on the Street hasn't changed its tune. RBC raised from $145 to $180, Truist from $160 to $185, and Scotiabank pushed all the way to $220. Piper Sandler's move was arguably the starkest: target up from $100 to $175 in a single step. The direction of travel is clearly upward, and the consensus mean price target now sits at $172, implying around 7% further from Tuesday's close. What the grouped action reveals is a Street that was caught underweight and is scrambling to reset. Multiple firms maintained Hold or Neutral while lifting targets — the classic post-beat repositioning that acknowledges the move without committing to it.
Short positioning is the more stubborn story. Bears hold 10.6% of the free float short — a level firmly in the high-conviction zone — and that figure has barely moved, down less than 1% on the week despite the 19% price surge. The absence of meaningful short covering is notable. Borrowing conditions give no signal of squeeze pressure: cost to borrow sits at just 0.46%, one of the lowest readings of the past 30 days, and availability is ample at over 800% — meaning there are roughly eight shares available to borrow for every share currently lent out. That wide availability kept the door open for shorts to hold or even reload rather than run. Short interest ticked up 3% over the past month before the earnings print, suggesting the position was being built into the catalyst rather than reduced ahead of it.
Options traders look calm rather than defensive. The put/call ratio edged up to 0.26 on Tuesday — just below one standard deviation above its 20-day mean of 0.25. That is well short of the elevated hedging readings seen in late June, when the PCR was running above 0.32. The near-year-low territory on the PCR back in July, when it touched 0.23, reflected a bullish setup into results; the mild pickup on Tuesday looks like routine rebalancing after the move rather than fresh caution. Across the peer group, the earnings-week cybersecurity rally was broad: CRWD rose 16% on the week, PANW climbed 15%, and TENB added 15% — so Qualys's 19% move outpaced its closest correlates, suggesting the company-specific beat carried incremental weight.
Insider activity adds a nuanced layer. CFO Joo Mi Kim sold approximately 1,600 shares across six tranches on August 3 for a combined ~$250,000 — small in dollar terms and low-significance trades, but worth noting as they came the day before the earnings release. On July 31, CEO Sumedh Thakar sold 6,748 shares at $144.75 for just under $1 million, and the Chief Legal Officer trimmed as well. These disposals cluster around a price roughly 10% below where the stock closed this week, and while the gross 90-day net figure shows $8.5 million in net selling, none of the trades carry high significance scores. Execution into price weakness before a beat is a pattern that reads more as scheduled distribution than a bearish read on the company's own results.
With the next earnings event not scheduled until early November, the next chapter is less about whether Qualys can beat again and more about whether the 10%-plus short base begins to unwind — or digs in — as the stock approaches the $172 consensus target.
See the live data behind this article on ORTEX.
Open QLYS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
